{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:04:04Z","timestamp":1786979044287,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":155,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540790877","type":"print"},{"value":"9783540790884","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-79088-4_15","type":"book-chapter","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T09:32:33Z","timestamp":1257413553000},"page":"327-354","source":"Crossref","is-referenced-by-count":11,"title":["Masking and Manipulation"],"prefix":"10.1007","author":[{"given":"Rosa","family":"Ventura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"15_CR1_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00498838","volume":"296","author":"U Abshagen","year":"1976","unstructured":"Abshagen U et al (1976) Pharmacokinetics of spironolactone in man. Naunyn Schmiedebergs Arch Pharmacol 296:37\u201345","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"15_CR2_15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-994204","volume":"33","author":"HA Adams","year":"1998","unstructured":"Adams HA et al (1998) Volume replacement solutions \u2013 pharmacology and clinical use. Anasthesiol Intensivmed Notfallmed Schmerzther 33:2\u201317","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"15_CR3_15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinchem\/48.4.629","volume":"48","author":"R Aguilera","year":"2002","unstructured":"Aguilera R et al (2002) Detection of epitestosterone doping by isotope ratio mass spectrometry. Clin Chem 48:629\u2013636","journal-title":"Clin Chem"},{"key":"15_CR4_15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0003-2670(02)01223-0","volume":"475","author":"L Amendola","year":"2003","unstructured":"Amendola L et al (2003) Rapid determination of diuretics in human urinbe by gas chromatography\u2013mass spectrometry following microwave assisted derivatization. Anal Chim Acta 475:125\u2013136","journal-title":"Anal Chim Acta"},{"key":"15_CR5_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0773.1981.tb00897.x","volume":"49","author":"F Andreasen","year":"1981","unstructured":"Andreasen F et al (1981) The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products. Acta Pharmacol Toxicol (Copenh) 49:223\u2013229","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"15_CR6_15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.ju.0000139539.94828.29","volume":"172","author":"G Andriole","year":"2004","unstructured":"Andriole G et al (2004) Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 172:1399\u20131403","journal-title":"J Urol"},{"key":"15_CR7_15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1249\/00005768-198508000-00009","volume":"17","author":"LE Armstrong","year":"1985","unstructured":"Armstrong LE et al (1985) Influence of diuretic-induced dehydration on competitive running performance. Med Sci Sports Exerc 17:456\u2013461","journal-title":"Med Sci Sports Exerc"},{"key":"15_CR8_15","first-page":"371","volume-title":"Recent advances in doping analysis (12)","author":"L Avois","year":"2004","unstructured":"Avois L et al (2004) Rapid screening of HES in urine with colorimetric detection. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (12). SportVerlag Strauss, K\u00f6ln, pp 371\u2013376"},{"key":"15_CR9_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-4347(96)00392-1","volume":"690","author":"MB Barroso","year":"1997","unstructured":"Barroso MB et al (1997) Gas chromatographic\u2013mass spectrometric analysis of the loop diuretic torasemide in human urine. J Chromatogr B Biomed Sci Appl 690:105\u2013113","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"15_CR10_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00607430","volume":"12","author":"B Beermann","year":"1977","unstructured":"Beermann B, Groschinsky-Grind M (1977) Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol 12:297\u2013303","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR11_15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cpt1976195part1531","volume":"19","author":"B Beermann","year":"1976","unstructured":"Beermann B et al (1976) Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther 19:531\u2013537","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR12_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cpt1977224385","volume":"22","author":"B Beermann","year":"1977","unstructured":"Beermann B et al (1977) Pharmacokinetics of bendroflumethiazide. Clin Pharmacol Ther 22:385\u2013388","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR13_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2091-6-12","volume":"6","author":"V Bellemare","year":"2005","unstructured":"Bellemare V et al (2005) Characterization of 17alpha-hydroxysteroid dehydrogenase activity (17alpha-HSD) and its involvement in the biosynthesis of epitestosterone. BMC Biochem 6:12","journal-title":"BMC Biochem"},{"key":"15_CR14_15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.ftd.0000160719.96445.91","volume":"27","author":"J Beyer","year":"2005","unstructured":"Beyer J et al (2005) Screening procedure for detection of diuretics and uricosurics and\/or their metabolites in human urine using gas chromatography\u2013mass spectrometry after extractive methylation. Ther Drug Monit 27:509\u2013520","journal-title":"Ther Drug Monit"},{"key":"15_CR15_15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/14656566.8.9.1337","volume":"8","author":"J Bhardwa","year":"2007","unstructured":"Bhardwa J et al (2007) Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia. Expert Opin Pharmacother 8:1337\u20131344","journal-title":"Expert Opin Pharmacother"},{"key":"15_CR16_15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00003088-199018050-00004","volume":"18","author":"LL Boles Ponto","year":"1990","unstructured":"Boles Ponto LL, Schoenwald RD (1990) Furosemide: a pharmacokinetic\/pharmacodynamic review (part I). Clin Pharmacokinet 18:381\u2013408","journal-title":"Clin Pharmacokinet"},{"key":"15_CR17_15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.1983.175","volume":"34","author":"DC Brater","year":"1983","unstructured":"Brater DC et al (1983a) Effects of piretanide in normal subjects. Clin Pharmacol Ther 34:324\u2013330","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR18_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/clpt.1983.154","volume":"34","author":"DC Brater","year":"1983","unstructured":"Brater DC et al (1983b) Bumetanide and furosemide. Clin Pharmacol Ther 34:207\u2013213","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR19_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0039-128X(64)90028-5","volume":"4","author":"RV Brooks","year":"1964","unstructured":"Brooks RV, Giuliani G (1964) Epitestosterone:isolation from human urine and experiments on possible precursors. Steroids 4:101\u2013116","journal-title":"Steroids"},{"key":"15_CR20_15","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/jssc.200500387","volume":"29","author":"C Brunelli","year":"2006","unstructured":"Brunelli C et al (2006) High-speed gas chromatography in doping control:fast-GC and fast-GC\/MS determination of beta-adrenoceptor ligands and diuretics. J Sep Sci 29:2765\u20132771","journal-title":"J Sep Sci"},{"key":"15_CR21_15","first-page":"671","volume-title":"Goodman & Gilman\u2019s The pharmacological basis of therapeutics","author":"A Burke","year":"2005","unstructured":"Burke A et al (2005) Analgesic-antipyretic agents; pharmacotherapy of gout. Goodman & Gilman\u2019s The pharmacological basis of therapeutics. McGraw-Hill, Medical Publishing Division, New York, pp 671\u2013715"},{"key":"15_CR22_15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2165\/00007256-198704040-00005","volume":"4","author":"JE Caldwell","year":"1987","unstructured":"Caldwell JE (1987) Diuretic therapy and exercise performance. Sports Med 4:290\u2013304","journal-title":"Sports Med"},{"key":"15_CR23_15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1152\/jappl.1984.57.4.1018","volume":"57","author":"JE Caldwell","year":"1984","unstructured":"Caldwell JE et al (1984a) Differential effects of sauna-, diuretic-, and exercise-induced hypohydration. J Appl Physiol 57:1018\u20131023","journal-title":"J Appl Physiol"},{"key":"15_CR24_15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00913847.1984.11701873","volume":"12","author":"JE Caldwell","year":"1984","unstructured":"Caldwell JE et al (1984b) Diuretic therapy, physical performance, and neuromuscular function. Physician Sportsmed 12:73\u201385","journal-title":"Physician Sportsmed"},{"key":"15_CR25_15","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1080\/01483919108049412","volume":"14","author":"P Camp\u00edns","year":"1991","unstructured":"Camp\u00edns P et al (1991) Solid-phaseextraction techniques for assay of diuretics in human urine samples. J Liq Chromatogr 14:3575\u20133590","journal-title":"J Liq Chromatogr"},{"key":"15_CR26_15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-4347(93)80170-9","volume":"612","author":"P Camp\u00edns","year":"1993","unstructured":"Camp\u00edns P et al (1993) Improved detection limits for screening of diuretics by coupled liquid chromatography and ultraviolet-visible spectrophotometry. J Chromatogr B Biomed Appl 612:245\u2013251","journal-title":"J Chromatogr B Biomed Appl"},{"key":"15_CR27_15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/ac00074a011","volume":"66","author":"P Camp\u00edns","year":"1994","unstructured":"Campins and Falc\u00f3 (1994) Column-switching techniques for screening of diuretics and probenecid in urine samples. Anal Chem 66:244\u2013248","journal-title":"Anal Chem"},{"issue":"5","key":"15_CR28_15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2164\/jandrol.108.005025","volume":"29","author":"O Canguven","year":"2008","unstructured":"Canguven O, Burnett AL (2008) The Effect of 5 {alpha}-reductase inhibitors on erectile function. J Androl 29(5):514\u2013523","journal-title":"J Androl"},{"key":"15_CR29_15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-9556(25)08559-9","volume":"20","author":"JR Carlin","year":"1992","unstructured":"Carlin JR et al (1992) Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. Drug Metab Dispos 20:148\u2013155","journal-title":"Drug Metab Dispos"},{"key":"15_CR30_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0021-9673(94)89116-8","volume":"683","author":"D Carreras","year":"1994","unstructured":"Carreras D et al (1994) Comparison of derivatization procedures for the determination of diuretics in urine by gas chromatography\u2013mass spectrometry. J Chromatogr A 683:195\u2013202","journal-title":"J Chromatogr A"},{"key":"15_CR31_15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0039-128X(02)00005-3","volume":"67","author":"DH Catlin","year":"2002","unstructured":"Catlin DH et al (2002) Effects of androstenedione administration on epitestosterone metabolism in men. Steroids 67:559\u2013564","journal-title":"Steroids"},{"key":"15_CR32_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.forsciint.2004.02.031","volume":"143","author":"AT Cawley","year":"2004","unstructured":"Cawley AT et al (2004) Searching for new markers of endogenous steroid administration in athletes: \u201clooking outside the metabolic box\u201d. Forensic Sci Int 143:103\u2013114","journal-title":"Forensic Sci Int"},{"key":"15_CR33_15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003495-198428030-00001","volume":"28","author":"M Chaffman","year":"1984","unstructured":"Chaffman M et al (1984) Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 28:189\u2013235","journal-title":"Drugs"},{"key":"15_CR34_15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1985.tb02655.x","volume":"19","author":"DJ Chapron","year":"1985","unstructured":"Chapron DJ et al (1985) Influence of advanced age on the disposition of acetazolamide. Br J Clin Pharmacol 19:363\u2013371","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR35_15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00003495-198529060-00002","volume":"29","author":"SP Clissold","year":"1985","unstructured":"Clissold SP, Brogden RN (1985) Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 29:489\u2013530","journal-title":"Drugs"},{"key":"15_CR36_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-4347(00)82884-4","volume":"489","author":"SF Cooper","year":"1989","unstructured":"Cooper SF et al (1989) Comprehensive screening procedure for diuretics in urine by high-performance liquid chromatography. J Chromatogr 489:65\u201388","journal-title":"J Chromatogr"},{"key":"15_CR37_15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.steroids.2008.01.026","volume":"73","author":"DA Cowan","year":"2008","unstructured":"Cowan DA et al (2008) Ion trap MS\/MS of intact testosterone and epitestosterone conjugates \u2013 adducts, fragile ions and the advantages of derivatisation. Steroids 73:621\u2013628","journal-title":"Steroids"},{"key":"15_CR38_15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003088-198106020-00004","volume":"6","author":"RF Cunningham","year":"1981","unstructured":"Cunningham RF et al (1981) Clinical pharmacokinetics of probenecid. Clin Pharmacokinet 6:135\u2013151","journal-title":"Clin Pharmacokinet"},{"key":"15_CR39_15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-197904040-00002","volume":"4","author":"RE Cutler","year":"1979","unstructured":"Cutler RE, Blair AD (1979) Clinical pharmacokinetics of frusemide. Clin Pharmacokinet 4:279\u2013296","journal-title":"Clin Pharmacokinet"},{"key":"15_CR40_15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0021-9673(00)96050-3","volume":"325","author":"F Croo De","year":"1985","unstructured":"De Croo F et al (1985) High-performance liquid chromatographic behaviour of some pharmaceutically important thiazide, loop and potassium-sparing diuretics. J Chromatogr 325:395\u2013411","journal-title":"J Chromatogr"},{"key":"15_CR41_15","volume-title":"Recent advances in doping analysis (4)","author":"X Torre de la","year":"1997","unstructured":"de la Torre X et al (1997) Testosterone detection in different ethnic groups. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (4). Sport & Buch Strauss, K\u00f6ln"},{"key":"15_CR42_15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0960-0760(93)90025-R","volume":"44","author":"L Dehennin","year":"1993","unstructured":"Dehennin L (1993) Secretion by the human testis of epitestosterone, with its sulfoconjugate and precursor androgen 5-androstene-3 beta, 17 alpha-diol. J Steroid Biochem Mol Biol 44:171\u2013177","journal-title":"J Steroid Biochem Mol Biol"},{"key":"15_CR43_15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0731-7085(85)80017-0","volume":"3","author":"FT Delbeke","year":"1985","unstructured":"Delbeke FT, Debackere M (1985) The influence of diuretics on the excretion and metabolism of doping agents \u2013 I. Mephentermine. J Pharm Biomed Anal 3:141\u2013148","journal-title":"J Pharm Biomed Anal"},{"key":"15_CR44_15","first-page":"134","volume":"36","author":"FT Delbeke","year":"1986","unstructured":"Delbeke FT, Debackere M (1986a) The influence of diuretics on the excretion and metabolism of doping agents. II. Phentermine. Arzneimittelforschung 36:134\u2013137","journal-title":"Arzneimittelforschung"},{"key":"15_CR45_15","first-page":"1413","volume":"36","author":"FT Delbeke","year":"1986","unstructured":"Delbeke FT, Debackere M (1986b) The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. Arzneimittelforschung 36:1413\u20131416","journal-title":"Arzneimittelforschung"},{"key":"15_CR46_15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bod.2510090203","volume":"9","author":"FT Delbeke","year":"1988","unstructured":"Delbeke FT, Debackere M (1988) The influence of diuretics on the excretion and metabolism of doping agents. Part IV \u2013 Caffeine. Biopharm Drug Dispos 9:137\u2013145","journal-title":"Biopharm Drug Dispos"},{"key":"15_CR47_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0731-7085(91)80232-X","volume":"9","author":"FT Delbeke","year":"1991","unstructured":"Delbeke FT, Debackere M (1991a) The influence of diuretics on the excretion and metabolism of doping agents \u2013 V. Dimefline. J Pharm Biomed Anal 9:23\u201328","journal-title":"J Pharm Biomed Anal"},{"key":"15_CR48_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.2510120105","volume":"12","author":"FT Delbeke","year":"1991","unstructured":"Delbeke FT, Debackere M (1991b) The influence of diuretics on the excretion and metabolism of doping agents: Part VI. Pseudoephedrine. Biopharm Drug Dispos 12:37\u201348","journal-title":"Biopharm Drug Dispos"},{"key":"15_CR49_15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/bmc.201","volume":"16","author":"K Deventer","year":"2002","unstructured":"Deventer K et al (2002) Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography\u2013tandem mass spectrometry. Biomed Chromatogr 16:529\u2013535","journal-title":"Biomed Chromatogr"},{"key":"15_CR50_15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/rcm.1744","volume":"19","author":"K Deventer","year":"2005","unstructured":"Deventer K et al (2005) Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography\/mass spectrometry with scan-to-scan polarity switching. Rapid Commun Mass Spectrom 19:90\u201398","journal-title":"Rapid Commun Mass Spectrom"},{"key":"15_CR51_15","first-page":"71","volume-title":"Recent advances in doping analysis (14)","author":"K Deventer","year":"2006","unstructured":"Deventer K et al (2006) Improved clean-up for the detection of hydroxyethylstarch (HES). In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (14). SportVerlag Strauss, K\u00f6ln, pp 71\u201378"},{"key":"15_CR52_15","unstructured":"Dirks JH and Sutton RAL (1986) Diuretics. Physiology, pharmacology and clinical use, Elsevier Health Sciences (1), pp 396"},{"key":"15_CR53_15","first-page":"14","volume":"35","author":"M Donike","year":"1984","unstructured":"Donike M et al (1984) Routinebestimmung von Anabolika in Harn. Dstch Z Sportmedizin 35:14\u201324","journal-title":"Dstch Z Sportmedizin"},{"key":"15_CR54_15","first-page":"235","volume":"35","author":"M Donike","year":"1995","unstructured":"Donike M et al (1995) Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5 alpha-metabolites. J Sports Med Phys Fitness 35:235\u2013250","journal-title":"J Sports Med Phys Fitness"},{"key":"15_CR55_15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/rcm.1290060508","volume":"6","author":"JD Ehrhardt","year":"1992","unstructured":"Ehrhardt JD (1992) Negative-ion mass spectra of methylated diuretics. Rapid Commun Mass Spectrom 6:349\u2013351","journal-title":"Rapid Commun Mass Spectrom"},{"key":"15_CR56_15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/clinchem\/34.7.1462","volume":"34","author":"O Falk","year":"1988","unstructured":"Falk O et al (1988) Effect of ethanol on the ratio between testosterone and epitestosterone in urine. Clin Chem 34:1462\u20131464","journal-title":"Clin Chem"},{"key":"15_CR57_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jps.2600620304","volume":"62","author":"PW Feit","year":"1973","unstructured":"Feit PW et al (1973) GLC determination and urinary recovery of bumetanide in healthy volunteers. J Pharm Sci 62:375\u2013379","journal-title":"J Pharm Sci"},{"key":"15_CR58_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00563556","volume":"15","author":"HL Fleuren","year":"1979","unstructured":"Fleuren HL et al (1979a) Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration. Eur J Clin Pharmacol 15:35\u201350","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR59_15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jps.2600680837","volume":"68","author":"HL Fleuren","year":"1979","unstructured":"Fleuren HL et al (1979b) Differential potentiometric method for determining dissociation constants of very slightly water-soluble drugs applied to the sulfonamide diuretic chlorthalidone. J Pharm Sci 68:1056\u20131058","journal-title":"J Pharm Sci"},{"key":"15_CR60_15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/jaoac\/81.5.948","volume":"81","author":"SD Garbis","year":"1998","unstructured":"Garbis SD et al (1998) Detection of thiazide-based diuretics in equine urine by liquid chromatography\/mass spectrometry. J AOAC Int 81:948\u2013957","journal-title":"J AOAC Int"},{"key":"15_CR61_15","unstructured":"Geyer H et al (1993) Probenecid as masking agent in doping \u2013 inhibition of the urinary excretion of steroid glucuronides. In: Proceedings 10th cologne workshop on dope analysis. Sport und Buch Strauss, Editio Sport, K\u00f6ln, pp 141\u2013150"},{"key":"15_CR62_15","first-page":"71","volume-title":"Recent advances in doping analysis (7)","author":"H Geyer","year":"1999","unstructured":"Geyer H et al (1999) Finasteride \u2013 a substance for manipulation in dope control? In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (7). Sport & Buch StrauB, K\u00f6ln, pp 71\u201380"},{"key":"15_CR63_15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2004-819955","volume":"25","author":"H Geyer","year":"2004","unstructured":"Geyer H et al (2004) Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids \u2013 results of an international study. Int J Sports Med 25:124\u2013129","journal-title":"Int J Sports Med"},{"key":"15_CR64_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00543797","volume":"25","author":"HJ Gilfrich","year":"1983","unstructured":"Gilfrich HJ et al (1983) Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability. Eur J Clin Pharmacol 25:237\u2013241","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR65_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aca.2003.09.062","volume":"502","author":"C Goebel","year":"2004","unstructured":"Goebel C et al (2004) Rapid screening method for diuretics in doping control using automated solid phase extraction and liquid-chromatography\u2013electrospray tandem mass spectrometry. Anal Chim Acta 502:65\u201374","journal-title":"Anal Chim Acta"},{"key":"15_CR66_15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/chromsci\/41.5.261","volume":"41","author":"R Gonzalo-Lumbreras","year":"2003","unstructured":"Gonzalo-Lumbreras R et al (2003) Development and method validation for testosterone and epitestosterone in human urine samples by liquid chromatography applications. J Chromatogr Sci 41:261\u2013265","journal-title":"J Chromatogr Sci"},{"key":"15_CR67_15","first-page":"197","volume-title":"Recent advances in doping analysis (14)","author":"S Guddat","year":"2004","unstructured":"Guddat S et al (2004) Detection and quantification of the plasma volume expander dextran in human urine. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (14). SportVerlag Strauss, K\u00f6ln, pp 197\u2013202"},{"key":"15_CR68_15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/bmc.509","volume":"19","author":"S Guddat","year":"2005","unstructured":"Guddat S et al (2005) Identification and quantification of the plasma volume expander dextran in human urine by liquid chromatography-tandem mass spectrometry of enzymatically derived isomaltose. Biomed Chromatogr 19:743\u2013750","journal-title":"Biomed Chromatogr"},{"key":"15_CR69_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00644964","volume":"16","author":"U Gundert-Remy","year":"1979","unstructured":"Gundert-Remy U et al (1979) Plasma and urinary levels of triamterene and certain metabolites after oral administration to man. Eur J Clin Pharmacol 16:39\u201344","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR70_15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/rcm.1491","volume":"18","author":"R Guti\u00e9rrez Gallego","year":"2004","unstructured":"Guti\u00e9rrez Gallego R, Segura J (2004) Rapid screening of plasma volume expanders in urine using matrix-assisted laser desorption\/ionisation time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 18:1324\u20131330","journal-title":"Rapid Commun Mass Spectrom"},{"key":"15_CR71_15","first-page":"383","volume-title":"Recent advances in doping analysis (13)","author":"R Gutierrez Gallego","year":"2005","unstructured":"Gutierrez Gallego R et al (2005) A microtiter assay to detect the presence of glucose-based plasma volume expanders in urine. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (13). SportVerlag Strauss, K\u00f6ln, pp 383\u2013386"},{"key":"15_CR72_15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jat\/16.3.194","volume":"16","author":"HW Hagedorn","year":"1992","unstructured":"Hagedorn HW, Schulz R (1992) Detection of diuretics in horse urine by GC\/MS. J Anal Toxicol 16:194\u2013198","journal-title":"J Anal Toxicol"},{"key":"15_CR73_15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cpt1977222179","volume":"22","author":"SC Halladay","year":"1977","unstructured":"Halladay SC et al (1977) Diuretic effect and metabolism of bumetanide in man. Clin Pharmacol Ther 22:179\u2013187","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR74_15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF01059034","volume":"10","author":"J Hasegawa","year":"1982","unstructured":"Hasegawa J et al (1982) Pharmacokinetics of triamterene and its metabolite in man. J Pharmacokinet Biopharm 10:507\u2013523","journal-title":"J Pharmacokinet Biopharm"},{"key":"15_CR75_15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chroma.2005.05.065","volume":"1082","author":"C He","year":"2005","unstructured":"He C et al (2005) Extraction of testosterone and epitestosterone in human urine using aqueous two-phase systems of ionic liquid and salt. J Chromatogr A 1082:143\u2013149","journal-title":"J Chromatogr A"},{"key":"15_CR76_15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/an9810600557","volume":"106","author":"UGG Henning","year":"1981","unstructured":"Henning UGG et al (1981a) Benzothiadiazine dissociation constants. Part I. Ultraviolet spectrophotometric pKa determinations. Analyst 106:557\u2013564","journal-title":"Analyst"},{"key":"15_CR77_15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/an9810600565","volume":"106","author":"UGG Henning","year":"1981","unstructured":"Henning UGG et al (1981b) Benzothiadiazine dissociation constants. Part II. The order of deprotonation. Analyst 106:565\u2013573","journal-title":"Analyst"},{"key":"15_CR78_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/01971528408062996","volume":"5","author":"W Hepner","year":"1984","unstructured":"Hepner W et al (1984) A radioimmunoassay to measure piretanide in human serum and urine. J Immunoassay 5:13\u201327","journal-title":"J Immunoassay"},{"key":"15_CR79_15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/jps.2600730821","volume":"73","author":"AA Holazo","year":"1984","unstructured":"Holazo AA et al (1984) Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects. J Pharm Sci 73:1108\u20131113","journal-title":"J Pharm Sci"},{"key":"15_CR80_15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/ciia.2006.1.4.425","volume":"1","author":"SJ Hudak","year":"2006","unstructured":"Hudak SJ et al (2006) Role of 5 alpha-reductase inhibitors in the management of prostate cancer. Clin Interv Aging 1:425\u2013431","journal-title":"Clin Interv Aging"},{"key":"15_CR81_15","first-page":"737","volume-title":"Goodman & Gilman\u2019s The pharmacological basis of therapeutics","author":"E Jackson","year":"2005","unstructured":"Jackson E (2005) Diuretics. Goodman & Gilman\u2019s The pharmacological basis of therapeutics. McGraw-Hill, Medical Publishing Division, New York, pp 737\u2013769"},{"key":"15_CR82_15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1039\/B310111H","volume":"129","author":"C Jimenez","year":"2004","unstructured":"Jimenez C et al (2004) Reference materials for analytical toxicology including doping control: freeze-dried urine samples. Analyst 129:449\u2013455","journal-title":"Analyst"},{"key":"15_CR83_15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/rcm.2387","volume":"20","author":"C Jimenez","year":"2006","unstructured":"Jimenez C et al (2006) Stability studies of testosterone and epitestosterone glucuronides in urine. Rapid Commun Mass Spectrom 20:858\u2013864","journal-title":"Rapid Commun Mass Spectrom"},{"key":"15_CR84_15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200544070-00002","volume":"44","author":"C Jungheinrich","year":"2005","unstructured":"Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44:681\u2013699","journal-title":"Clin Pharmacokinet"},{"key":"15_CR85_15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1213\/00000539-200209000-00007","volume":"95","author":"C Jungheinrich","year":"2002","unstructured":"Jungheinrich C et al (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130\/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 95:544\u2013551; table","journal-title":"Anesth Analg"},{"key":"15_CR86_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(96)00204-6","volume":"687","author":"T Karila","year":"1996","unstructured":"Karila T et al (1996) High doses of alcohol increase urinary testosterone-to-epitestosterone ratio in females. J Chromatogr B Biomed Appl 687:109\u2013116","journal-title":"J Chromatogr B Biomed Appl"},{"key":"15_CR87_15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cpt1976192158","volume":"19","author":"A Karim","year":"1976","unstructured":"Karim A et al (1976a) Spironolactone. I. Disposition and metabolism. Clin Pharmacol Ther 19:158\u2013169","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR88_15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cpt1976192170","volume":"19","author":"A Karim","year":"1976","unstructured":"Karim A et al (1976b) Spironolactone. II. Bioavailability. Clin Pharmacol Ther 19:170\u2013176","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR89_15","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/clinchem\/41.11.1617","volume":"41","author":"AT Kicman","year":"1995","unstructured":"Kicman AT et al (1995) Proposed confirmatory procedure for detecting 5 alpha-dihydrotestosterone doping in male athletes. Clin Chem 41:1617\u20131627","journal-title":"Clin Chem"},{"key":"15_CR90_15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2265.1999.00742.x","volume":"50","author":"AT Kicman","year":"1999","unstructured":"Kicman AT et al (1999) Adrenal and gonadal contributions to urinary excretion and plasma concentration of epitestosterone in men\u2013effect of adrenal stimulation and implications for detection of testosterone abuse. Clin Endocrinol (Oxf) 50:661\u2013668","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15_CR91_15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aca.2006.12.028","volume":"585","author":"M Kolmonen","year":"2007","unstructured":"Kolmonen M et al (2007) A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography\/time-of-flight mass spectrometry. Anal Chim Acta 585:94\u2013102","journal-title":"Anal Chim Acta"},{"key":"15_CR92_15","doi-asserted-by":"crossref","unstructured":"Kuuranne T (2009) Phase-II-metabolism of androgens and its relevancy for doping control analysis. Handbook of Experimental Pharmacology (in press)","DOI":"10.1007\/978-3-540-79088-4_3"},{"key":"15_CR93_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00003495-198529010-00003","volume":"29","author":"A Lant","year":"1985","unstructured":"Lant A (1985a) Diuretics. Clinical pharmacology and therapeutic use (Part I). Drugs 29:57\u201387","journal-title":"Drugs"},{"key":"15_CR94_15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2165\/00003495-198529020-00003","volume":"29","author":"A Lant","year":"1985","unstructured":"Lant A (1985b) Diuretics. Clinical pharmacology and therapeutic use (Part II). Drugs 29:162\u2013188","journal-title":"Drugs"},{"key":"15_CR95_15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-4347(91)80033-9","volume":"563","author":"AM Lisi","year":"1991","unstructured":"Lisi AM et al (1991) Screening for diuretics in human urine by gas chromatography\u2013mass spectrometry with derivatisation by direct extractive alkylation. J Chromatogr 563:257\u2013270","journal-title":"J Chromatogr"},{"key":"15_CR96_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-4347(92)80447-X","volume":"581","author":"AM Lisi","year":"1992","unstructured":"Lisi AM et al (1992) Diuretic screening in human urine by gas chromatography\u2013mass spectrometry: use of a macroreticular acrylic copolymer for the efficient removal of the coextracted phase-transfer reagent after derivatization by direct extractive alkylation. J Chromatogr 581:57\u201363","journal-title":"J Chromatogr"},{"key":"15_CR97_15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/elps.200600543","volume":"28","author":"M Lu","year":"2007","unstructured":"Lu M et al (2007) A new method for screening and determination of diuretics by on-line CE-ESI-MS. Electrophoresis 28:1461\u20131471","journal-title":"Electrophoresis"},{"key":"15_CR98_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)11692-3","volume":"117","author":"TH Maren","year":"1956","unstructured":"Maren TH (1956) Carbonic anhydrase inhibition.V.N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances. J Pharmacol Exp Ther 117:385\u2013401","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR99_15","unstructured":"Marques MAS et al (1999) Effect of finasteride on urinary steroid profile: a case study. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (7). Sport and Buch Strauss, K\u00f6ln, pp 317\u2013322"},{"key":"15_CR100_15","unstructured":"Mazzarino M and Botre F (2008) Fast screening for the detection of HES and dextran. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (16). Sport und Buch Strauss, K\u00adln, pp 329\u2013332"},{"key":"15_CR101_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00302-3","volume":"69","author":"R Mehvar","year":"2000","unstructured":"Mehvar R (2000) Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Release 69:1\u201325","journal-title":"J Control Release"},{"key":"15_CR102_15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.2600650615","volume":"65","author":"S Melethil","year":"1976","unstructured":"Melethil S, Conway WD (1976) Urinary excretion of probenecid and its metabolites in humans as a function of dose. J Pharm Sci 65:861\u2013865","journal-title":"J Pharm Sci"},{"key":"15_CR103_15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jcp.34.4.361","volume":"34","author":"JM Mishler","year":"1981","unstructured":"Mishler JM et al (1981) Urinary excretion kinetics of hydroxyethyl starch 350\/0.60 in normovolaemic man. J Clin Pathol 34:361\u2013365","journal-title":"J Clin Pathol"},{"key":"15_CR104_15","volume-title":"Clarke\u2019s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material","author":"AC Moffat","year":"2004","unstructured":"Moffat AC et al (2004) Clarke\u2019s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material, 3rd edn. Pharmaceutical Press, Paris","edition":"3"},{"key":"15_CR105_15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chroma.2006.09.034","volume":"1135","author":"V Morra","year":"2006","unstructured":"Morra V et al (2006) Fast gas chromatographic\/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis. J Chromatogr A 1135:219\u2013229","journal-title":"J Chromatogr A"},{"key":"15_CR106_15","first-page":"11","volume":"26","author":"Y Orita","year":"1976","unstructured":"Orita Y et al (1976) A metal complexing property of furosemide and bumetanide: determination of pK and stability constant. Arzneimittelforschung 26:11\u201313","journal-title":"Arzneimittelforschung"},{"key":"15_CR107_15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jat\/14.2.84","volume":"14","author":"SJ Park","year":"1990","unstructured":"Park SJ et al (1990) Systematic analysis of diuretic doping agents by HPLC screening and GC\/MS confirmation. J Anal Toxicol 14:84\u201390","journal-title":"J Anal Toxicol"},{"key":"15_CR108_15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jps.2600730317","volume":"73","author":"RB Patel","year":"1984","unstructured":"Patel RB et al (1984) Bioavailability of hydrochlorothiazide from tablets and suspensions. J Pharm Sci 73:359\u2013361","journal-title":"J Pharm Sci"},{"key":"15_CR109_15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2007.07.018","volume":"386","author":"L Politi","year":"2007","unstructured":"Politi L et al (2007) A direct screening procedure for diuretics in human urine by liquid chromatography-tandem mass spectrometry with information dependent acquisition. Clin Chim Acta 386:46\u201352","journal-title":"Clin Chim Acta"},{"key":"15_CR110_15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.chroma.2008.01.045","volume":"1183","author":"OJ Pozo","year":"2008","unstructured":"Pozo OJ et al (2008) Direct quantification of steroid glucuronides in human urine by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 1183:108\u2013118","journal-title":"J Chromatogr A"},{"key":"15_CR111_15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jchromb.2004.06.010","volume":"809","author":"NV Ramakrishna","year":"2004","unstructured":"Ramakrishna NV et al (2004) Selective and rapid liquid chromatography-tandem mass spectrometry assay of dutasteride in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 809:117\u2013124","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"15_CR112_15","first-page":"159","volume":"41","author":"E Raynaud","year":"1993","unstructured":"Raynaud E et al (1993) Study of urinary excretion of testosterone and epitestosterone glucuronides in children and adolescents. Pathol Biol (Paris) 41:159\u2013163","journal-title":"Pathol Biol (Paris)"},{"key":"15_CR113_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00562454","volume":"12","author":"W Riess","year":"1977","unstructured":"Riess W et al (1977) Pharmacokinetic studies with chlorthalidone (Hygroton) in man. Eur J Clin Pharmacol 12:375\u2013382","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR114_15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00003495-199855050-00002","volume":"55","author":"JS Roberts","year":"1998","unstructured":"Roberts JS, Bratton SL (1998) Colloid volume expanders. Problems, pitfalls and possibilities. Drugs 55:621\u2013630","journal-title":"Drugs"},{"key":"15_CR115_15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00609957","volume":"32","author":"K Sabanathan","year":"1987","unstructured":"Sabanathan K et al (1987) A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients. Eur J Clin Pharmacol 32:53\u201360","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR116_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-4347(96)00396-9","volume":"690","author":"S Salado","year":"1997","unstructured":"Salado S, Vera-Avila LE (1997) On-line solid-phase extraction and high-performance liquid chromatographic determination of chlorthalidone in urine. J Chromatogr B Biomed Sci Appl 690:195\u2013202","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"15_CR117_15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1034\/j.1399-6576.2003.00220.x","volume":"47","author":"O Sander","year":"2003","unstructured":"Sander O et al (2003) Equivalence of hydroxyethyl starch HES 130\/0. 4 and HES 200\/0. 5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 47:1151\u20131158","journal-title":"Acta Anaesthesiol Scand"},{"key":"15_CR118_15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jms.166","volume":"36","author":"V Sanz-Nebot","year":"2001","unstructured":"Sanz-Nebot V et al (2001) Determination and characterization of diuretics in human urine by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry. J Mass Spectrom 36:652\u2013657","journal-title":"J Mass Spectrom"},{"key":"15_CR119_15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jchromb.2006.07.010","volume":"844","author":"C Saudan","year":"2006","unstructured":"Saudan C et al (2006) Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 844:168\u2013174","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"15_CR120_15","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.forsciint.2008.01.003","volume":"178","author":"C Saudan","year":"2008","unstructured":"Saudan C et al (2008) Short term impact of Tribulus terrestris intake on doping control analysis of endogenous steroids. Forensic Sci Int 178(1):e7\u2013e10","journal-title":"Forensic Sci Int"},{"issue":"7","key":"15_CR121_15","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2008-0218","volume":"93","author":"JJ Schulze","year":"2008","unstructured":"Schulze JJ et al (2008) Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93(7):2500\u20132506","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR122_15","volume-title":"Recent andvances in doping analysis (16)","author":"S Simoes","year":"2005","unstructured":"Simoes S et al (2005) 5-Alpha reductase inhibitors detection in doping analyses. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent andvances in doping analysis (16). Sport und Buch Straub, K\u00f6ln"},{"key":"15_CR123_15","volume-title":"Recent advances in doping analysis (16)","author":"RE Simoni","year":"2008","unstructured":"Simoni RE et al (2008) Screening for HES in human urine and possible application for dextran. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (16). Sport und Buch Straub, K\u00f6ln"},{"key":"15_CR124_15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1440-2440(00)80050-X","volume":"3","author":"GJ Slater","year":"2000","unstructured":"Slater GJ et al (2000) Beta-hydroxy beta-methylbutyrate (HMB) supplementation does not influence the urinary testosterone: epitestosterone ratio in healthy males. J Sci Med Sport 3:79\u201383","journal-title":"J Sci Med Sport"},{"key":"15_CR125_15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0090-9556(25)00282-X","volume":"8","author":"DE Smith","year":"1980","unstructured":"Smith DE et al (1980) Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab Dispos 8:337\u2013342","journal-title":"Drug Metab Dispos"},{"key":"15_CR126_15","first-page":"423","volume-title":"Recent advances in doping analysis (14)","author":"J Son","year":"2006","unstructured":"Son J et al (2006) Screening and confirmation analyses of urinary plasma volume expanders, deextran and HES, in doping control. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (14). SportVerlag Strauss, K\u00f6ln, pp 423\u2013426"},{"key":"15_CR127_15","first-page":"427","volume-title":"Recent advances in doping analysis (14)","author":"YM Sook","year":"2006","unstructured":"Sook YM et al (2006) Rapid screening of plasma volume expanders using Benedict\u2019s solution. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (14). SportVerlag Strauss, K\u00f6ln, pp 427\u2013430"},{"key":"15_CR128_15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/clpt.1985.176","volume":"38","author":"F Sorgel","year":"1985","unstructured":"Sorgel F et al (1985) Oral triamterene disposition. Clin Pharmacol Ther 38:306\u2013312","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR129_15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.forsciint.2007.04.001","volume":"174","author":"PE Sottas","year":"2008","unstructured":"Sottas PE et al (2008) From population- to subject-based limits of T\/E ratio to detect testosterone abuse in elite sports. Forensic Sci Int 174:166\u2013172","journal-title":"Forensic Sci Int"},{"key":"15_CR130_15","doi-asserted-by":"crossref","unstructured":"Sottas P-E, Robinson N, Saugy M (2009) The athlete\u2019s biological passport and indirect markers of blood doping. Handbook of Experimental Pharmacology (in press)","DOI":"10.1007\/978-3-540-79088-4_14"},{"key":"15_CR131_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0960-0760(92)90014-A","volume":"42","author":"GJ Southan","year":"1992","unstructured":"Southan GJ et al (1992) Possible indices for the detection of the administration of dihydrotestosterone to athletes. J Steroid Biochem Mol Biol 42:87\u201394","journal-title":"J Steroid Biochem Mol Biol"},{"key":"15_CR132_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0960-0760(03)00383-2","volume":"87","author":"L Starka","year":"2003","unstructured":"Starka L (2003) Epitestosterone. J Steroid Biochem Mol Biol 87:27\u201334","journal-title":"J Steroid Biochem Mol Biol"},{"key":"15_CR133_15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jssc.200600280","volume":"30","author":"A Stopforth","year":"2007","unstructured":"Stopforth A et al (2007) Quantification of testosterone and epitestosterone in human urine samples by stir bar sorptive extraction \u2013 thermal desorption \u2013 gas chromatography\/mass spectrometry: application to HIV-positive urine samples. J Sep Sci 30:257\u2013265","journal-title":"J Sep Sci"},{"key":"15_CR134_15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0378-4347(00)00251-6","volume":"744","author":"M Thevis","year":"2000","unstructured":"Thevis M et al (2000a) Detection of the plasma volume expander hydroxyethyl starch in human urine. J Chromatogr B Biomed Sci Appl 744:345\u2013350","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"15_CR135_15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-9888(200001)35:1<77::AID-JMS916>3.0.CO;2-L","volume":"35","author":"M Thevis","year":"2000","unstructured":"Thevis M et al (2000b) Mass spectrometry of partially methylated alditol acetates derived from hydroxyethyl starch. J Mass Spectrom 35:77\u201384","journal-title":"J Mass Spectrom"},{"key":"15_CR136_15","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1021\/ac020020e","volume":"74","author":"M Thevis","year":"2002","unstructured":"Thevis M et al (2002) Mass spectrometric behavior of thiazide-based diuretics after electrospray ionization and collision-induced dissociation. Anal Chem 74:3802\u20133808","journal-title":"Anal Chem"},{"key":"15_CR137_15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FTD.0b013e31803bb85d","volume":"29","author":"M Thevis","year":"2007","unstructured":"Thevis M et al (2007a) Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite. Ther Drug Monit 29:236\u2013247","journal-title":"Ther Drug Monit"},{"key":"15_CR138_15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00216-006-1112-z","volume":"388","author":"M Thevis","year":"2007","unstructured":"Thevis M et al (2007b) Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples. Anal Bioanal Chem 388:1539\u20131543","journal-title":"Anal Bioanal Chem"},{"key":"15_CR139_15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-4347(01)00058-5","volume":"757","author":"D Thieme","year":"2001","unstructured":"Thieme D et al (2001) Screening, confirmation and quantification of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 757:49\u201357","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"15_CR140_15","first-page":"245","volume-title":"Recent advances in doping analysis","author":"J Th\u00f6rngren","year":"2007","unstructured":"Th\u00f6rngren J et al (2007) A new approach for screening, verifying and confirmation of prohibited doping substances. In: Schaenzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis. Sportverlag Strauss, K\u00f6ln, pp 245\u2013252"},{"key":"15_CR141_15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.juro.2007.11.033","volume":"179","author":"DJ Tindall","year":"2008","unstructured":"Tindall DJ, Rittmaster RS (2008) The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer. J Urol 179:1235\u20131242","journal-title":"J Urol"},{"key":"15_CR142_15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1517\/13543784.16.9.1425","volume":"16","author":"A Tiwari","year":"2007","unstructured":"Tiwari A (2007) Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia. Expert Opin Invest Drugs 16:1425\u20131439","journal-title":"Expert Opin Invest Drugs"},{"key":"15_CR143_15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0731-7085(91)80046-C","volume":"9","author":"FY Tsai","year":"1991","unstructured":"Tsai FY et al (1991) Analysis of diuretic doping agents by HPLC screening and GC\u2013MSD confirmation. J Pharm Biomed Anal 9:1069\u20131076","journal-title":"J Pharm Biomed Anal"},{"key":"15_CR144_15","unstructured":"Ventura R (1994) Development of analytical methods to detect the administration of forbidden substances in sport: diuretics, probenecid and mesocarb. PhD Thesis"},{"key":"15_CR145_15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-4347(96)00279-4","volume":"687","author":"R Ventura","year":"1996","unstructured":"Ventura R, Segura J (1996) Detection of diuretic agents in doping control. J Chromatogr B Biomed Appl 687:127\u2013144","journal-title":"J Chromatogr B Biomed Appl"},{"key":"15_CR146_15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0378-4347(91)80621-I","volume":"562","author":"R Ventura","year":"1991","unstructured":"Ventura R et al (1991) Approach to the analysis of diuretics and masking agents by high-performance liquid chromatography\u2013mass spectrometry in doping control. J Chromatogr 562:723\u2013736","journal-title":"J Chromatogr"},{"key":"15_CR147_15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0021-9673(93)83228-K","volume":"655","author":"R Ventura","year":"1993","unstructured":"Ventura R et al (1993) Fast screening method for diuretics, probenecid and other compounds of doping interest. J Chromatogr A 655:233\u2013242","journal-title":"J Chromatogr A"},{"key":"15_CR148_15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1255\/ejms.920","volume":"14","author":"R Ventura","year":"2008","unstructured":"Ventura R et al (2008) High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents. Eur J Mass Spectrom 14:191\u2013200","journal-title":"Eur J Mass Spectrom"},{"key":"15_CR149_15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tmrv.2004.11.006","volume":"19","author":"A Vercueil","year":"2005","unstructured":"Vercueil A et al (2005) Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfus Med Rev 19:93\u2013109","journal-title":"Transfus Med Rev"},{"key":"15_CR150_15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00126839-200304030-00002","volume":"4","author":"J Waitzinger","year":"2003","unstructured":"Waitzinger J et al (2003) Hydroxyethyl starch (HES) [130\/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 4:149\u2013157","journal-title":"Drugs R D"},{"key":"15_CR151_15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","volume":"7","author":"PG Welling","year":"1986","unstructured":"Welling PG (1986) Pharmacokinetics of the thiazide diuretics. Biopharm Drug Dispos 7:501\u2013535","journal-title":"Biopharm Drug Dispos"},{"key":"15_CR152_15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1023\/A:1016409606936","volume":"4","author":"RL Williams","year":"1987","unstructured":"Williams RL et al (1987) Effects of formulation and food on the absorption of hydrochlorothiazide and triamterene or amiloride from combination diuretic products. Pharm Res 4:348\u2013352","journal-title":"Pharm Res"},{"key":"15_CR153_15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jcem-26-8-902","volume":"26","author":"H Wilson","year":"1966","unstructured":"Wilson H, Lipsett MB (1966) Metabolism of epitestosterone in man. J Clin Endocrinol Metab 26:902\u2013914","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR154_15","unstructured":"World Anti-Doping Agency (WADA) (2007) The 2008 prohibited list"},{"key":"15_CR155_15","unstructured":"Hansch C and Leo (2008) A partition coefficient data bank, MEDCHEM Project. Pomonba College, Claremont, CA"}],"container-title":["Handbook of Experimental Pharmacology","Doping in Sports"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-79088-4_15.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T21:28:51Z","timestamp":1739395731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-79088-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540790877","9783540790884"],"references-count":155,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-79088-4_15","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}